Naveh Pharma

Company Overview

Snapshot

Founded in October 1996, Naveh Pharma operates with 11–50 employees. The company was acquired by Diplomat Holdings in September 2022, marking a significant exit for the pharmaceutical and healthcare products developer.

Business overview

Naveh Pharma specializes in the development and manufacturing of pharmaceuticals and other healthcare products, including nutritional supplements and natural drugs. The company's product portfolio features magnesium-based supplements like Magnox Osteo for bone health and Magnox Lady for premenstrual syndrome relief, alongside proprietary pharmaceutical products for ear, nose, and throat conditions. Naveh Pharma also acts as a licensed distributor for prescription pharmaceuticals, over-the-counter medicines, and natural health products, serving markets across Israel, Europe, and Australia.

Strategic signal

In September 2022, Naveh Pharma was acquired by Diplomat Holdings. This acquisition signals Diplomat Holdings' strategic move to diversify its activities beyond its traditional import and distribution of Procter & Gamble brands, expanding its footprint in the pharmaceutical and nutritional products market. For Naveh Pharma, this represents a successful exit and an opportunity for continued growth under a larger corporate umbrella.

Company Intelligence Q&A

What was a significant corporate milestone for Naveh Pharma?

Naveh Pharma was acquired by Diplomat Holdings in September 2022. This acquisition allowed Diplomat Holdings to diversify its activities within the pharmaceutical and nutritional products market.

Did Naveh Pharma launch any new products in 2022?

In April 2022, Naveh Pharma launched new products, including a natural dietary supplement based on saffron. These new offerings aimed to alleviate suffering and improve the quality of life for individuals, with products targeting mental health, joint pain, and fibromyalgia.

What strategic partnership did Naveh Pharma enter into in 2022?

In March 2022, Naveh Pharma entered a strategic partnership with Saffron Tech, a subsidiary of Sativus Tech Corp, to create a joint venture. This collaboration aimed to develop and distribute saffron-based food supplements globally and launch a line of saffron-based cosmetics.

What is Naveh Pharma's primary focus in product development?

Naveh Pharma primarily focuses on developing and manufacturing pharmaceuticals and healthcare products, with a notable emphasis on nutritional supplements, particularly those containing magnesium, and natural drugs. The company also develops proprietary products for ear, nose, and throat conditions.

What markets does Naveh Pharma serve?

Naveh Pharma serves various global markets, including Russia, Japan, Greece, Taiwan, India, China, the United Kingdom, the United States, Poland, Italy, Germany, and France, distributing prescription pharmaceuticals, over-the-counter medicines, and natural health products.